Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 4/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 2/20 | 0.41 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.41 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.41 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.41 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12669289 | 1.00 | DNM1 (0.46) | DNM1CA1CA12CA2CA9 | |
| Bromide SCHEMBL5769744 | 0.98 | DNM1 (0.48) | DNM1CA1CA12CA2CA9 | |
| SCHEMBL17676601 | 0.91 | DNM1 (0.42) | DNM1CA1CA12CA2CA9 | |
| SCHEMBL17676553 | 0.91 | DNM1 (0.42) | DNM1CA1CA12CA2CA9 | |
| SCHEMBL8654027 | 0.90 | CA1 (0.43) | CA1CA12CA2CA9 | |
| SCHEMBL15746839 | 0.88 | DNM1 (0.39) | DNM1CA1CA12CA2CA9 | |
| SCHEMBL10312297 | 0.85 | CA1 (0.52) | CA1CA12CA2CA9 | |
| SCHEMBL15648362 | 0.83 | GPR84 (0.43) | TSHR | |
| SCHEMBL16204456 | 0.83 | DNM1 (0.33) | DNM1CA1CA12CA2CA9 | |
| SCHEMBL2126416 | 0.82 | DNM1 (0.48) | DNM1CA1CA12CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5328884-A | Salicylic acid salt,and amide or sulfonamide as developer | KANZAKI PAPER MANUFACTURING CO., LTD. (JP) | 1994-07-12 | — | — | US | claimed |
| US-5250108-A | Mixture of salicylic acid salt, amide and sulfonamide compounds | KANZAKI PAPER MANUFACTURING CO. LTD. (JP) | 1993-10-05 | — | — | US | claimed |
| US-20200131335-A1 | SURFACE ACTIVE ADJUVANT | RHODIA OPERATIONS (FR) | 2020-04-30 | — | — | US | disclosed |
| EP-3612604-A1 | SURFACE ACTIVE ADJUVANT | Rhodia Operations (FR) | 2020-02-26 | — | — | EP | disclosed |
| WO-2020035124-A1 | SURFACE ACTIVE ADJUVANT FOR COATINGS | RHODIA OPERATIONS (FR) | 2020-02-20 | — | — | WO | disclosed |
| WO-2018193009-A1 | SURFACE ACTIVE ADJUVANT | RHODIA OPERATIONS (FR) | 2018-10-25 | — | — | WO | disclosed |
| CN-102459536-B | Lubricating oil composition | IDEMITSU KOSAN CO | 2014-06-25 | — | — | CN | disclosed |
| US-8314050-B2 | Material for pressure measurement | FUJIFILM CORPORATION (JP) | 2012-11-20 | — | — | US | disclosed |
| US-20120135904-A1 | LUBRICANT COMPOSITION | IDEMITSU KOSAN CO., LTD. (JP) | 2012-05-31 | — | — | US | disclosed |
| US-20120122840-A1 | COMPOUNDS AND THERAPEUTIC USES THEREOF | MYREXIS, INC. (US) | 2012-05-17 | — | — | US | disclosed |
| CN-102459536-A | lubricating oil composition | IDEMITSU KOSAN CO | 2012-05-16 | — | — | CN | disclosed |
| EP-2444474-A1 | LUBRICANT COMPOSITION | Idemitsu Kosan Co., Ltd. (JP) | 2012-04-25 | — | — | EP | disclosed |
| CN-101688812-B | Material for pressure measurement | FUJI PHOTO FILM CO LTD | 2011-11-09 | — | — | CN | disclosed |
| US-20100323188-A1 | MATERIAL FOR PRESSURE MEASUREMENT | FUJIFILM CORPORATION (JP) | 2010-12-23 | — | — | US | disclosed |
| CN-101688812-A | Material for pressure measurement | FUJIFILM CORP | 2010-03-31 | — | — | CN | disclosed |
| US-7211609-B2 | Warp-free pigment compositions comprising phthalocyanine pigments | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-05-01 | — | — | US | disclosed |
| US-5328884-A | Salicylic acid salt,and amide or sulfonamide as developer | KANZAKI PAPER MANUFACTURING CO., LTD. (JP) | 1994-07-12 | — | — | US | disclosed |
| US-5250108-A | Mixture of salicylic acid salt, amide and sulfonamide compounds | KANZAKI PAPER MANUFACTURING CO. LTD. (JP) | 1993-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120122840-A1 | COMPOUNDS AND THERAPEUTIC USES THEREOF | VHL, TP53, ASAH2 | DNM1 836/4885CA1 2596/4885CA12 175/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.